About Source BioScience

SourceBio is a leading international provider of integrated state-of-the-art laboratory services and products with a focus on improving patient diagnosis, management and care. Group revenues are derived from four core business units:

Healthcare Diagnostics including Cell and Digital Pathology, Genomics, Stability Storage and Precision Medicine.

SourceBio International plc (SBI) is listed on the AIM market of the London Stock Exchange.